Selected article for: "effective treatment and nasopharyngeal swab"

Author: Ekawat Pasomsub; Siriorn P. Watcharananan; Kochawan Boonyawat; Pareena Janchompoo; Garanyuta Wongtabtim; Worramin Suksuwan; Somnuek Sungkanuparph; Angsana Phuphuakrat
Title: Saliva Sample as a Non-Invasive Specimen for the Diagnosis of Coronavirus Disease-2019 (COVID-19): a Cross-Sectional Study
  • Document date: 2020_4_22
  • ID: 0bbzo9cp_2
    Snippet: Detection of SARS-CoV-2 in patient specimens is the first crucial step for the 57 guidance of treatment, effective infection control in the hospital and control of infection in 58 the community. Screening of infection in suspected cases with a nucleic acid amplification 59 test (NAAT), such as real-time polymerase chain reaction (RT-PCR), in respiratory 60 specimens, is recommended by the World Health Organization [4] . However, the collection 61.....
    Document: Detection of SARS-CoV-2 in patient specimens is the first crucial step for the 57 guidance of treatment, effective infection control in the hospital and control of infection in 58 the community. Screening of infection in suspected cases with a nucleic acid amplification 59 test (NAAT), such as real-time polymerase chain reaction (RT-PCR), in respiratory 60 specimens, is recommended by the World Health Organization [4] . However, the collection 61 of nasopharyngeal and/or oropharyngeal swab specimens is a relatively invasive method and 62 the procedure might put healthcare workers at higher risk for disease transmission during 63 patients' gag reflex, cough, or sneezing. 64

    Search related documents:
    Co phrase search for related documents